Santhera Shares Rise 0.82% as Swiss Market Holds Steady – Mid‑Cap Growth Outlook
Santhera shares rise 0.82% amid Swiss market stability, showing a steady mid‑cap performance and a promising pipeline for neuromuscular and metabolic drugs.
- SANTHERA PHARMACEUTICALS
- Switzerland
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read